Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2007 1
2008 2
2010 5
2011 7
2012 5
2013 2
2014 5
2015 6
2016 7
2018 2
2019 7
2020 6
2021 9
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab.
Paul F, Marignier R, Palace J, Arrambide G, Asgari N, Bennett JL, Cree BAC, De Sèze J, Fujihara K, Kim HJ, Hornby R, Huda S, Kissani N, Kleiter I, Kuwabara S, Lana-Peixoto M, Law L, Leite MI, Pandit L, Pittock SJ, Quan C, Ramanathan S, Rotstein D, Saiz A, Sato DK, Vaknin-Dembinsky A. Paul F, et al. Among authors: vaknin dembinsky a. Neurol Neuroimmunol Neuroinflamm. 2023 May 31;10(4):e200124. doi: 10.1212/NXI.0000000000200124. Print 2023 Jul. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37258412 Free PMC article.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Tur C, Dubessy AL, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M, Abboud H, Achiron A, Bellinvia A, Boyko A, Casanova JL, Clifford D, Dobson R, Farez MF, Filippi M, Fitzgerald KC, Fonderico M, Gouider R, Hacohen Y, Hellwig K, Hemmer B, Kappos L, Ladeira F, Lebrun-Frénay C, Louapre C, Magyari M, Mehling M, Oreja-Guevara C, Pandit L, Papeix C, Piehl F, Portaccio E, Ruiz-Camps I, Selmaj K, Simpson-Yap S, Siva A, Sorensen PS, Sormani MP, Trojano M, Vaknin-Dembinsky A, Vukusic S, Weinshenker B, Wiendl H, Winkelmann A, Zuluaga Rodas MI, Tintoré M, Stankoff B. Tur C, et al. Among authors: vaknin dembinsky a. Mult Scler. 2022 Aug;28(9):1424-1456. doi: 10.1177/13524585211069068. Epub 2022 Feb 23. Mult Scler. 2022. PMID: 35196927 Review.
IL-6 as a marker for NMOSD disease activity.
Haramati A, Rechtman A, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A. Haramati A, et al. Among authors: vaknin dembinsky a. J Neuroimmunol. 2022 Sep 15;370:577925. doi: 10.1016/j.jneuroim.2022.577925. Epub 2022 Jul 2. J Neuroimmunol. 2022. PMID: 35810527
RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammation.
Ben-David Y, Kagan S, Cohen Ben-Ami H, Rostami J, Mizrahi T, Kulkarni AR, Thakur GA, Vaknin-Dembinsky A, Healy LM, Brenner T, Treinin M. Ben-David Y, et al. Among authors: vaknin dembinsky a. Int Immunopharmacol. 2020 Jun;83:106381. doi: 10.1016/j.intimp.2020.106381. Epub 2020 Mar 14. Int Immunopharmacol. 2020. PMID: 32179243
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel.
Brill L, Ganelin-Cohen E, Dabby R, Rabinowicz S, Zohar-Dayan E, Rein N, Aloni E, Karmon Y, Vaknin-Dembinsky A. Brill L, et al. Among authors: vaknin dembinsky a. Front Neurol. 2021 Jan 21;11:612304. doi: 10.3389/fneur.2020.612304. eCollection 2020. Front Neurol. 2021. PMID: 33584514 Free PMC article.
Central nervous system vasculitis.
Gotkine M, Vaknin-Dembinsky A. Gotkine M, et al. Among authors: vaknin dembinsky a. Curr Treat Options Neurol. 2013 Jun;15(3):367-74. doi: 10.1007/s11940-013-0227-8. Curr Treat Options Neurol. 2013. PMID: 23475760
78 results